AURA 241220 12.50P (AURA241220P12500) Stock Options, News & Quotes

Account Info

Log Out

US OptionsDetailed Quotes

AURA241220P12500

Watchlist

0.00
0.000.00%

15min DelayTrading Dec 19 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Buy Recommendation for Aura Biosciences Inc. Based on Promising Clinical Data and Growth Prospects
TipRanksDec 17 16:55 ET
Aura Biosciences Price Target Lowered to $21 From $23 at JMP Securities
TipRanksDec 5 06:41 ET
Muscle Invasive Bladder Cancer Drug Pipeline Market Research 2024 Featuring Aura Biosciences, Janssen Research & Development, Asieris Pharmaceuticals, and RemeGen
Yahoo FinanceDec 2 04:31 ET
Aura Biosciences to Participate in the 7th Annual Evercore ISI HealthCONx Conference
GlobeNewswireNov 26 08:00 ET
BTIG Maintains Aura Biosciences(AURA.US) With Buy Rating, Maintains Target Price $24
Moomoo NewsNov 14 08:35 ET · Ratings
Scotiabank Maintains Aura Biosciences(AURA.US) With Buy Rating, Maintains Target Price $23
Moomoo NewsNov 14 08:35 ET · Ratings

Comments

PeterChen2

Dec 5 16:38

A lesson of collapse

$Aura Biosciences (AURA.US)$

Thatmyname

Oct 18 08:25

$Aura Biosciences (AURA.US)$ Thisssss

Trytosaveabit

Oct 17 15:10

News

$Aura Biosciences (AURA.US)$ Reuters· 1 min ago!
Multiple Clinical Complete Responses Demonstrated Following Single Low Dose Administration of Bel-SAR in Patients With Non-Muscle-Invasive Bladder Cancer (Nmibc) in Ongoing Phase 1 Trial! No adverse events

Jaguar8

Sep 12 07:23

NEWS

$Aura Biosciences (AURA.US)$
Aura Biosciences Reports Positive Phase 2 End of Study Results Evaluating Bel-sar as a First-Line Treatment for Early-Stage Choroidal Melanoma
Aura Biosciences (NASDAQ: AURA) reported positive Phase 2 end of study results for bel-sar (AU-011) in treating early-stage choroidal melanoma (CM). The study showed an 80% tumor control rate and 90% visual acuity preservationamong Phase 3-eligible patients. Bel-sar demonstrated a highly favorable safety profile with no tre...

Stock_Drift

Sep 12 07:09

$Aura Biosciences (AURA.US)$
via @Lnova 📊⚡️📊

Lnova: [Share Link: Aura Biosciences' Eye Cancer Therapy Shows Promise in Mid-Stage Study]